---
title: "Merz Pharmaceuticals LLC and others v Viatris Santé (UPC CoA 917/2025, 27-04-2026)"
description: "The Court of Appeal set aside the Paris Local Division's refusal for delay and granted Merz a provisional injunction and delivery-up against Viatris Santé's…"
url: https://pitch.law/academy/upc-court-of-appeal/upc-coa-917-2025-2026-04-27
lang: en
author: "UPC Case Law by Pitch"
editor: "Bart Lieben"
datePublished: 2026-11-18T10:07:32.765Z
dateModified: 2026-11-18T10:07:32.765Z
---

# Merz Pharmaceuticals LLC and others v Viatris Santé

Order of the UPC Court of Appeal of 27 April 2026, UPC CoA 917/2025.

UPC Case Law by Pitch, edited by [Bart Lieben](https://pitch.law/team/bart-lieben) · Published 18-11-2026

## TL;DR

The Court of Appeal set aside the Paris Local Division's refusal for delay and granted Merz a provisional injunction and delivery-up against Viatris Santé's generic fampridine in France until the SPC expires on 25 July 2026. Publishing a generic's French price and reimbursement listing did not make the SPC holder aware of an imminent launch, so the clock for delay under R 211.4 RoP had not started. A defendant may also simply drop an invalidity defence in provisional measures proceedings, without any formal amendment or withdrawal.

## Key holding

An invalidity defence raised in proceedings for provisional measures is not a separate action. Waiving it is neither an amendment of the case under R 263 RoP nor a withdrawal under R 265 RoP. Under Art 76(2) UPCA the Court proceeds on the issues that remain, and it may order the waiving party to pay the costs the other side incurred on the dropped arguments. Delay under R 211.4 RoP runs from actual or constructive awareness of an (imminent) infringement. The publication of a generic's price and reimbursement listing in France does not, on its own, give the right holder that awareness, because Art 3 of the LEEM–CEPS framework agreement imposes no obligation to launch within six months.

## Questions decided

1. How is an invalidity defence waived in provisional measures proceedings, and with what cost consequences?
2. When may new evidence be admitted on appeal under R 222.2 RoP?
3. Does publication of a generic's French price and reimbursement listing start the delay period under R 211.4 RoP?
4. Does a CEPS notice to a third party's lawyer give the SPC holder knowledge of an imminent launch?
5. Do product shortages, healthcare costs or a short remaining SPC term outweigh the need for a provisional injunction?
6. Should a generic be allowed to stay on the market against a guarantee?

## Case details

- Court: Court of Appeal of the Unified Patent Court, Panel 2
- Panel: Ingeborg Simonsson (presiding judge and judge-rapporteur); Patricia Rombach and Bart van den Broek (legally qualified judges); Anna Hedberg and Jeroen Meewisse (technically qualified judges)
- Date: 27-04-2026
- Case number(s): UPC CoA 917/2025, UPC CFI 697/2025
- Parties: Appellants: Merz Pharmaceuticals LLC, Merz Therapeutics GmbH and Merz Pharma France (applicants at first instance); Respondent: Viatris Santé (defendant at first instance)
- Language of the proceedings: English
- Outcome: The Court of Appeal set aside the Local Division's order of 21 November 2025.

## How to cite

Court of Appeal, Merz Pharmaceuticals LLC and others v Viatris Santé, UPC CoA 917/2025, Order of 27 April 2026 (OSCOLA)

## Full summary

Read the full analyses for free — create a free account: https://pitch.law/academy/upc-court-of-appeal/upc-coa-917-2025-2026-04-27

Topics: [Provisional measures](https://pitch.law/academy/upc-court-of-appeal/topics/provisional-measures), [Procedure](https://pitch.law/academy/upc-court-of-appeal/topics/procedure)

## In the same case

- [Merz Pharmaceuticals LLC and others v Viatris Santé, UPC CoA 917/2025, 26-01-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-917-2025-2026-01-26): The Court of Appeal declined to decide, for now, Merz's request under R 262.2 RoP to keep a new exhibit away from the public.

## More on provisional measures

- [Guardant Health, Inc. v Sophia Genetics SA and others, UPC CoA 49/2026, 05-11-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-49-2026-2026-11-05): The Court of Appeal set aside a EUR 600,000 award of representation costs because the successful party had backed it only with invoices reading "supply of legal services" and general assertions about complexity and urgency.
- [SharkNinja Operating LLC v Groupe SEB France and others, UPC CoA 61/2026, 21-08-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-61-2026-2026-08-21): The Court of Appeal overturned the Paris Local Division and granted SharkNinja a provisional injunction in France and Germany against SEB's "Cookeo Infinity" multicookers.
- [Amazon.com, Inc. and others v InterDigital VC Holdings, Inc. and others, UPC CoA 936/2025, 15-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-936-2025-2026-07-15): The Court of Appeal permitted InterDigital to withdraw its application for provisional measures against Amazon while Amazon's appeal was pending, and declared the proceedings closed.
- [AIM Sport Development AG v TGI Sport Suomi Oy and others, UPC CoA 108/2026, 08-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-108-2026-2026-07-08): The Court of Appeal's judge-rapporteur held that an appeal against a first-instance order disposing of an application for provisional measures is an appeal against a final decision under R 220.1(a) RoP, because R 363.2 RoP gives such orders that status.
- [Angelalign Technology Inc. and others v Align Technology, Inc., UPC CoA 36/2026, 08-07-2026](https://pitch.law/academy/upc-court-of-appeal/upc-coa-36-2026-2026-07-08): The Court of Appeal rejected Angelalign's appeal and upheld the Düsseldorf preliminary injunction against the "Live Now" feature of its iOrtho orthodontic planning software.
